Get started
Author

Vincenzo Caruso

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging
2010 · A. Pepe, A. Meloni, et al. · Haematologica · 150
PDF
Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy
2013 · Alessia Pepe, Antonella Meloni, et al. · Journal of Cardiovascular Magnetic Resonance · 138
PDF
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia
2019 · Antonio Piga, Silverio Perrotta, et al. · Blood · 120
PDF
Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach
2017 · Alessia Pepe, Antonella Meloni, et al. · European Heart Journal - Cardiovascular Imaging · 119
Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies
2009 · Aurelio Maggio, Angela Vitrano, et al. · Blood Cells Molecules and Diseases · 96
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry
2014 · Caterina Borgna‐Pignatti, Maria Chiara Garani, et al. · British Journal of Haematology · 86
PDF
Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major
2015 · Maddalena Casale, Antonella Meloni, et al. · Circulation Cardiovascular Imaging · 78
Long‐term sequential deferiprone–deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial
2009 · Aurelio Maggio, Angela Vitrano, et al. · British Journal of Haematology · 71
Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major
2014 · Antonella Meloni, Gennaro Restaino, et al. · International Journal of Cardiology · 67
Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study
2013 · Alessia Pepe, Antonella Meloni, et al. · British Journal of Haematology · 60
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?
2016 · Angela Vitrano, Giuseppina Calvaruso, et al. · British Journal of Haematology · 57
Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion‐dependent thalassaemia and HCV genotype 1 or 4 infection
2017 · A. Mangia, R. Sarli, et al. · Alimentary Pharmacology & Therapeutics · 39
PDF
Assessment and management of iron overload in β‐thalassaemia major patients during the 21st century: a real‐life experience from the I talian W ebthal project
2013 · Antonio Piga, Filomena Longo, et al. · British Journal of Haematology · 35
PDF
Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients
2012 · Aurelio Maggio, Angela Vitrano, et al. · American Journal of Hematology · 35
PDF
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major
2013 · Aldo Filosa, Angela Vitrano, et al. · Blood Cells Molecules and Diseases · 31
Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients
2015 · Paolo Ricchi, Antonella Meloni, et al. · American Journal of Hematology · 30
Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients
2015 · Alessia Pepe, Antonella Meloni, et al. · Journal of Cardiovascular Medicine · 28
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia
2022 · Antonio Piga, Filomena Longo, et al. · Therapeutic Advances in Hematology · 22
Sequential Alternating Deferiprone And Deferoxamine Treatment Compared To Deferiprone Monotherapy: Main Findings And Clinical Follow-Up Of A Large Multicenter Randomized Clinical Trial In -Thalassemia Major Patients
2011 · Gaetano Restivo Pantalone, Aurelio Maggio, et al. · Hemoglobin · 20
Serial echocardiographic left ventricular ejection fraction measurements: A tool for detecting thalassemia major patients at risk of cardiac death
2013 · Aurelio Maggio, Angela Vitrano, et al. · Blood Cells Molecules and Diseases · 18
PDF
Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up
2014 · G. Derchi, M. Balocco, et al. · Haematologica · 16
PDF
Luspatercept Increases Hemoglobin, Decreases Transfusion Burden and Improves Iron Overload in Adults with Beta-Thalassemia
2016 · Antonio G. Piga, Immacolata Tartaglione, et al. · Blood · 15
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
2016 · Vito Di Marco, Roberta D’Ambrosio, et al. · Digestive and Liver Disease · 12
Real‐life experience with liver iron concentration R 2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET
2016 · Angela Vitrano, Giuseppina Calvaruso, et al. · European Journal Of Haematology · 11
ACE-536 Increases Hemoglobin and Decreases Transfusion Burden and Serum Ferritin in Adults with Beta-Thalassemia: Preliminary Results from a Phase 2 Study
2014 · Antonio G. Piga, Silverio Perrotta, et al. · Blood · 11
Works count: 56
Citation count: 1,417
H-index: 19
I10-index: 25
Year
Topic
Type